Cell Guidance Systems Blog

The invention of induced pluripotent stem cell (iPSC) technology in 2006 by Shinya Yamanaka was a big moment for stem cell therapeutics. Using a cocktail of transcription factors to turn the clock back on (almost) any cell to its pluripotent past enables essentially unlimited quantities of any cell type to be made. iPSCs are similar to embryonic stem cells (ESCs) that had been isolated several years earlier. However, ESCs are derived from an early-stage embryo, so come with a lot of ethical baggage. Too much for many countries which simply banned the technique. As well as simpler ethics, iPSCs can be made using a patient’s own cells, enabling autologous cell therapy.

Cytokines/growth factors are large, related groups of highly potent proteins which affect cell fate. Cytokine potency is counter-balanced by relatively short half-lives. This ephemeral nature produces spatiotemporal effects by limiting duration of cytokine bioactivity and therefore the distance they can travel within tissues.

Exo-spinâ„¢ SEC columns can be used as a stand-alone product or as part of a combined strategy for isolating small EVs. CellGS offers pre-packed and equilibrated ready-to-use SEC columns. With the pore size of the resin being approximately 30 nm, Exo-spinâ„¢ SEC columns offer a highly pure exosome elution ready for any downstream application.